Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Melanoma recurrence in a previously dissected lymph node basin

M A Warso1, T K Das Gupta

  • 1Cancer Center, University of Illinois at Chicago.

Archives of Surgery (Chicago, Ill. : 1960)
|March 1, 1994
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A first-in-class, first-in-human, phase I trial of p28, a non-HDM2-mediated peptide inhibitor of p53 ubiquitination in patients with advanced solid tumours.

British journal of cancer·2013
Same author

Resveratrol inhibits rhabdomyosarcoma cell proliferation.

European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP)·2005
Same author

Induction of apoptosis in macrophages by Pseudomonas aeruginosa azurin: tumour-suppressor protein p53 and reactive oxygen species, but not redox activity, as critical elements in cytotoxicity.

Molecular microbiology·2003
Same author

The bacterial redox protein azurin induces apoptosis in J774 macrophages through complex formation and stabilization of the tumor suppressor protein p53.

Infection and immunity·2002
Same author

In vitro transformation of human congenital naevus to malignant melanoma.

Melanoma research·2002
Same author

Betulinic acid reduces ultraviolet-C-induced DNA breakage in congenital melanocytic naeval cells: evidence for a potential role as a chemopreventive agent.

Melanoma research·2001

Complete lymph node dissection is crucial for controlling cutaneous melanoma recurrence. While isolated nodal recurrence is uncommon, a second dissection can salvage some patients, highlighting the importance of meticulous surgical technique.

Area of Science:

  • Oncology
  • Surgical Oncology
  • Dermatology

Background:

  • Regional lymph node dissection is a standard procedure for managing cutaneous melanoma.
  • Assessing the impact of dissection completeness on regional control is vital.
  • Understanding outcomes for isolated nodal recurrence after lymphadenectomy is important.

Purpose of the Study:

  • To evaluate if complete lymph node dissection influences regional control in cutaneous melanoma.
  • To determine the effectiveness of a second lymph node dissection for isolated nodal recurrence.

Main Methods:

  • Retrospective case series analysis.
  • Minimum follow-up of 18 months.
  • Inclusion of patients with cutaneous melanoma and isolated nodal recurrence post-lymphadenectomy.

Related Experiment Videos

Main Results:

  • An overall isolated nodal recurrence rate of 2.7% was observed.
  • When the initial dissection was performed within the study institution, the recurrence rate was 0.8%.
  • Four patients achieved disease-free survival exceeding 3 years after a secondary lymphadenectomy.

Conclusions:

  • Complete lymphadenectomy with meticulous surgical technique is essential for optimal regional control in cutaneous melanoma.
  • Isolated nodal recurrence is infrequent, but salvage is possible with a subsequent dissection in select cases.